相关实验视频

Updated: Jul 23, 2025

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

通过MRE11封锁选择性杀死BRCA2缺乏的卵巢癌细胞

Adel Alblihy¹, Reem Ali¹, Mashael Algethami¹

¹Nottingham Biodiscovery Institute, School of Medicine, University of Nottingham, Nottingham NG7 3RD, UK.

International journal of molecular sciences

|July 14, 2023

概括

用Mirin阻断MRE11核酶会在缺乏BRCA2的卵巢癌细胞中引起合成致死性. 这突出了MRE11作为精密瘤治疗的潜在目标.

科学领域:

分子生物学分子生物学
癌症研究癌症研究
遗传学是一个遗传学.

背景情况:

MRE11核酶和BRCA2蛋白对于DNA修复过程至关重要,例如同源重组和复制.
缺乏BRCA2与各种癌症有关,特别是卵巢癌.

研究的目的:

调查BRCA2缺陷癌细胞中MRE11抑制诱导的合成致死性 (SL).
探索MRE11抑制剂在精密瘤学的治疗潜力.

主要方法:

利用Mirin,一个原型的MRE11抑制剂,以评估其对BRCA2缺乏和熟练细胞的影响.
进行了in silico分析以确认Mirin在MRE11上的结合部位.
研究了MRE11的淘汰效应,并分析了耐米林的模型.
研究了一组人类卵巢瘤的临床队列,检查MRE11/BRCA2表达和患者存活率之间的相关性.

主要成果:

在BRCA2缺乏细胞中,米林治疗诱导了合成致死性和增加了细胞毒性,其特征是DNA双链断裂,S相停止和亡.
米林特别抑制MRE11核酶活性,这是用核酶死亡的MRE11细胞进行的实验证实的.
在BRCA2缺陷细胞中,MRE11倒置降低了生存能力,而米林耐药性与53BP1下调和DNA修复上调有关.
在卵巢瘤中,低BRCA2和高MRE11表达与明显更差的无进展和整体存活相关.

结论:

MRE11是一种可行的合成致死性目标,用于精密瘤学.
像Mirin这样的MRE11抑制剂显示出对BRCA2缺乏癌症的治疗药物有前途.
针对MRE11可以为患有特定DNA修复缺陷的患者提供临床益处.

关键词:

这就是BRCA2的原因.在MRE11中,MRE11是MRE11中的一个.合成杀伤性合成杀伤性

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...